Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.

[1]  T. Kenri,et al.  Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains , 2019, PloS one.

[2]  Maureen H Diaz,et al.  Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  H. Yasunaga,et al.  Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections. , 2017, Respiratory investigation.

[4]  T. Nakano,et al.  Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015 , 2017, Emerging infectious diseases.

[5]  Mitchell F. Balish,et al.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond , 2017, Clinical Microbiology Reviews.

[6]  S. Pereyre,et al.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment , 2016, Front. Microbiol..

[7]  E. Stanford,et al.  Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective , 2016, Front. Microbiol..

[8]  R. Selvarangan,et al.  Macrolide-Resistant Mycoplasma pneumoniae, United States , 2015, Emerging infectious diseases.

[9]  Jae Hong Choi,et al.  Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011 , 2013, Emerging infectious diseases.

[10]  Y. Nishizawa,et al.  Nationwide Surveillance of Macrolide-Resistant Mycoplasma pneumoniae Infection in Pediatric Patients , 2013, Antimicrobial Agents and Chemotherapy.

[11]  H. Sakata,et al.  Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H. Tsutsumi,et al.  Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[13]  N. Miyashita,et al.  Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  Changying Lin,et al.  Nested PCR-Linked Capillary Electrophoresis and Single-Strand Conformation Polymorphisms for Detection of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, China , 2010, Journal of Clinical Microbiology.

[15]  H. von Baum,et al.  Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Morozumi,et al.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[17]  M. Morozumi,et al.  Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. , 2009, The Journal of antimicrobial chemotherapy.

[18]  M. Matsuoka,et al.  Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. , 2008, Journal of medical microbiology.

[19]  M. Korppi,et al.  Incidence of community‐acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population‐based study in primary health care , 2004, Respirology.

[20]  J. Jensen,et al.  A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995 , 1997, European Journal of Epidemiology.

[21]  J. Dankert,et al.  Mycoplasma pneumoniae P1 Type 1- and Type 2-Specific Sequences within the P1 Cytadhesin Gene of Individual Strains , 2001, Infection and Immunity.

[22]  Y. Arakawa,et al.  Characteristics of Macrolide‐Resistant Mycoplasma pneumoniae Strains Isolated from Patients and Induced with Erythromycin In Vitro , 2001, Microbiology and immunology.

[23]  J. Jensen,et al.  Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates , 2000, Epidemiology and Infection.

[24]  T. Kenri,et al.  Identification of a New Variable Sequence in the P1 Cytadhesin Gene of Mycoplasma pneumoniae: Evidence for the Generation of Antigenic Variation by DNA Recombination between Repetitive Sequences , 1999, Infection and Immunity.

[25]  Y. Sasaki,et al.  Epidemiological study of Mycoplasma pneumoniae infections in japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene , 1996, Journal of clinical microbiology.

[26]  I. Kahane.  In vitro studies on the mechanism of adherence and pathogenicity of mycoplasmas. , 1984, Israel journal of medical sciences.

[27]  A. M. Collier,et al.  Location of attachment moiety on Mycoplasma pneumoniae. , 1983, The Yale journal of biology and medicine.

[28]  D. C. Krause,et al.  Inhibition of Mycoplasma pneumoniae Hemadsorption and Adherence to Respiratory Epithelium by Antibodies to a Membrane Protein , 1983, Infection and immunity.

[29]  M. Cooney,et al.  Long-term epidemiology of infections with Mycoplasma pneumoniae. , 1979, The Journal of infectious diseases.

[30]  A. M. Collier,et al.  Respiratory infections due to Mycoplasma pneumoniae in infants and children. , 1975, Pediatrics.

[31]  G. Kenny,et al.  Epidemiology of Mycoplasma pneumoniae infection in families. , 1966, JAMA.